Smartleaf Asset Management LLC Akero Therapeutics, Inc. Transaction History
Smartleaf Asset Management LLC
- $610 Billion
- Q2 2024
A detailed history of Smartleaf Asset Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 172 shares of AKRO stock, worth $5,457. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172
Previous 70
145.71%
Holding current value
$5,457
Previous $1.68 Million
139.52%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AKRO
# of Institutions
170Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$218 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$177 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$172 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$166 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$162 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.47B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...